Atlas ITPP Cardarine SR9009 Tablets

Atlas ITPP Cardarine SR9009

Atlas tablets is offered in 2 variants: 25mg ITPP, 25mg Cardarine and 25mg SR9009, totaling 75mg per tablet for 20 tablets or 1500mg in total; and 25mg ITPP, 25mg Cardarine and 25mg SR9009, totaling 75mg per tablet for 40 tablets or 3000mg in total.

ITTP

ITTP or Myo-inositol trispyrophospate is a research compound currently being investigated in hopes of aiding patients weakened by myocardial infarctions due to its ability to increase oxygen supply to weakened or damaged cardiac muscle. Designed to make haemoglobin increase its release of oxygen above normal levels, ITPP has the potential ability to boost exercise levels in the ailing mice by up to 35% when given dissolved in water. When administered via injection into the abdomen, exercise levels saw potential rises up to a massive 60%. Further research is warranted to investigate the potential of ITPP in oxygen transport and endurance training.

 Cardarine

Cardarine, also known as GW-501516, is a PPAR agonist. Cardarine is used in research for its potential to facilitate fat-burning by increasing endurance and stamina. A study done on the effects of GW-501516 for enhancing running endurance in Kunming mice demonstrated that a 3-week treatment with GW501516 increased running performance of both trained and untrained mice. Like training, GW501516 promoted mitochondrial fatty acid oxidation and increased fat metabolism in muscle tissue. This could potentially lead to less demanding cardiovascular work, increasing weekly deficits, resulting in increased fat loss.

SR-9009

A recent study on diet-induced obese mice treated with SR9009 and SR9011 (i.e., two times a day for 30 days) have been reported to display decreased fat mass and markedly improved dyslipidemia and hyperglycemia. The activation of REV-ERB leads to the enhancement of circadian rhythm observed in mice. This affects behaviour, sleep cycle and some functions related to increment in energy production.